333 related articles for article (PubMed ID: 15827868)
1. The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men.
Välimäki VV; Piippo K; Välimäki S; Löyttyniemi E; Kontula K; Välimäki MJ
Osteoporos Int; 2005 Dec; 16(12):1633-40. PubMed ID: 15827868
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for clinical stress fractures in male military recruits: a prospective cohort study.
Välimäki VV; Alfthan H; Lehmuskallio E; Löyttyniemi E; Sahi T; Suominen H; Välimäki MJ
Bone; 2005 Aug; 37(2):267-73. PubMed ID: 15964254
[TBL] [Abstract][Full Text] [Related]
3. Molecularly defined lactose malabsorption, peak bone mass and bone turnover rate in young finnish men.
Enattah N; Välimäki VV; Välimäki MJ; Löyttyniemi E; Sahi T; Järvelä I
Calcif Tissue Int; 2004 Dec; 75(6):488-93. PubMed ID: 15365657
[TBL] [Abstract][Full Text] [Related]
4. Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men.
Välimäki VV; Alfthan H; Ivaska KK; Löyttyniemi E; Pettersson K; Stenman UH; Välimäki MJ
J Clin Endocrinol Metab; 2004 Aug; 89(8):3785-9. PubMed ID: 15292305
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor gene polymorphism, but not estradiol levels, is related to bone density in healthy adolescent boys: a cross-sectional and longitudinal study.
Lorentzon M; Lorentzon R; Bäckström T; Nordström P
J Clin Endocrinol Metab; 1999 Dec; 84(12):4597-601. PubMed ID: 10599725
[TBL] [Abstract][Full Text] [Related]
6. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men.
Van Pottelbergh I; Lumbroso S; Goemaere S; Sultan C; Kaufman JM
Clin Endocrinol (Oxf); 2001 Nov; 55(5):659-66. PubMed ID: 11894978
[TBL] [Abstract][Full Text] [Related]
7. Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alpha gene polymorphisms.
Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R
Bone; 2003 Apr; 32(4):412-20. PubMed ID: 12689685
[TBL] [Abstract][Full Text] [Related]
8. Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women.
Kim JG; Lim KS; Kim EK; Choi YM; Lee JY
Menopause; 2001; 8(3):222-8. PubMed ID: 11355046
[TBL] [Abstract][Full Text] [Related]
9. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
10. Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men.
Khosla S; Riggs BL; Atkinson EJ; Oberg AL; Mavilia C; Del Monte F; Melton LJ; Brandi ML
J Clin Endocrinol Metab; 2004 Apr; 89(4):1808-16. PubMed ID: 15070949
[TBL] [Abstract][Full Text] [Related]
11. Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women.
Erdogan MO; Yıldız H; Artan S; Solak M; Taşcıoğlu F; Dündar U; Eser B; Colak E
Osteoporos Int; 2011 Apr; 22(4):1219-25. PubMed ID: 20532479
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women.
Mizunuma H; Hosoi T; Okano H; Soda M; Tokizawa T; Kagami I; Miyamoto S; Ibuki Y; Inoue S; Shiraki M; Ouchi Y
Bone; 1997 Nov; 21(5):379-83. PubMed ID: 9356730
[TBL] [Abstract][Full Text] [Related]
13. [Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women].
Yang X; Zheng SR; Chen RJ; Chen SL; Fan ZH; Li H; Lu YH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):273-6. PubMed ID: 12895309
[TBL] [Abstract][Full Text] [Related]
14. No major effect of estrogen receptor gene polymorphisms on bone mineral density or bone loss in postmenopausal Danish women.
Bagger YZ; Jørgensen HL; Heegaard AM; Bayer L; Hansen L; Hassager C
Bone; 2000 Feb; 26(2):111-6. PubMed ID: 10678404
[TBL] [Abstract][Full Text] [Related]
15. PvuII and XbaI polymorphisms of the estrogen receptor gene and bone mineral density in a Bulgarian population sample.
Ivanova JT; Doukova PB; Boyanov MA; Popivanov PR
Hormones (Athens); 2007; 6(1):36-43. PubMed ID: 17324916
[TBL] [Abstract][Full Text] [Related]
16. Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Saarikoski S; Honkanen R; Mäenpää PH
J Bone Miner Res; 2000 Feb; 15(2):315-21. PubMed ID: 10703934
[TBL] [Abstract][Full Text] [Related]
17. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
Yoneda K; Tanji Y; Ikeda N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2002 Dec; 186(2):223-30. PubMed ID: 12213292
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women.
Yamada Y; Ando F; Niino N; Ohta S; Shimokata H
J Mol Med (Berl); 2002 Jul; 80(7):452-60. PubMed ID: 12110951
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom.
Albagha OM; McGuigan FE; Reid DM; Ralston SH
J Bone Miner Res; 2001 Jan; 16(1):128-34. PubMed ID: 11149476
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status as a determinant of peak bone mass in young Finnish men.
Välimäki VV; Alfthan H; Lehmuskallio E; Löyttyniemi E; Sahi T; Stenman UH; Suominen H; Välimäki MJ
J Clin Endocrinol Metab; 2004 Jan; 89(1):76-80. PubMed ID: 14715830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
